The treatment of head and neck cancer has evolved significantly over the past decade. While surgery, radiation therapy, and chemotherapy remain important treatment options, advances in cancer research have introduced targeted therapy as a more personalized approach for certain patients. This innovation is helping specialists treat cancer more precisely while minimizing damage to healthy tissues.
Targeted therapy works differently from traditional chemotherapy. Instead of attacking all rapidly dividing cells, targeted treatments focus on specific molecules, proteins, or pathways that cancer cells use to grow and spread. By interfering with these biological processes, targeted therapy can slow disease progression and improve treatment outcomes in selected cases.
Head and neck cancers often develop due to genetic and molecular changes within cells. Researchers have identified several targets that play a role in tumor growth. One of the most recognized targets is the epidermal growth factor receptor (EGFR), which is frequently overexpressed in head and neck cancers.
Potential benefits of targeted therapy may include:
- More focused treatment action
- Reduced impact on healthy tissues
- Improved disease control in selected patients
- Combination opportunities with radiation therapy
- Additional treatment options for recurrent disease
Not every patient is a candidate for targeted therapy. Treatment decisions depend on several factors, including cancer type, stage, overall health, previous treatments, and molecular characteristics of the tumor.
The evaluation process often involves:
Detailed Cancer Assessment
Specialists review pathology reports, imaging studies, and treatment history to determine suitability.
Molecular Testing
Certain cancers may undergo additional testing to identify biomarkers that help guide treatment planning.
Multidisciplinary Consultation
Head and neck surgeons, medical oncologists, radiation oncologists, and rehabilitation specialists frequently collaborate to develop individualized treatment strategies.
Targeted therapy is commonly used in situations where surgery may not be sufficient on its own, where cancer has recurred, or where advanced disease requires a more comprehensive treatment approach.
Patients often ask whether targeted therapy replaces traditional treatments. In many cases, it does not. Instead, it may complement surgery, radiation, or chemotherapy as part of an integrated treatment plan.
As cancer care continues to advance in Chennai and across Tamil Nadu, access to personalized treatment options has expanded. This allows eligible patients to benefit from therapies that were not widely available in previous years.
The Face Clinic in Tambaram, Chennai, participates in the evaluation and management of complex head and neck cancer cases, helping patients understand available treatment options and appropriate referral pathways when advanced therapies are indicated.
Cancer treatment is increasingly moving toward precision medicine. For many patients, targeted therapy represents an important step in delivering care that is tailored not only to the disease itself but also to the unique biological characteristics of each individual.
